These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36185186)

  • 21. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y; Fu F; Chen H
    Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
    Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations.
    Qu R; Ye F; Tu D; Cai Y; Fu X
    Front Oncol; 2021; 11():785777. PubMed ID: 35096585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
    Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
    Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.
    Moon Y; Lee KY; Park JK
    J Thorac Dis; 2017 Oct; 9(10):3782-3792. PubMed ID: 29268386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Segmentectomy versus lobectomy for ground-glass opacity dominant cT1N0 invasive lung adenocarcinoma.
    Ma Z; Zhang Y; Han H; Wang S; Li Y; Chen H
    Transl Lung Cancer Res; 2024 Jun; 13(6):1201-1209. PubMed ID: 38973943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
    Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
    Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
    Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
    Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-center experience of simultaneous bilateral uni-portal video-assisted thoracoscopic surgery for multiple ground-glass opacities.
    Qu R; Hao Z; Zhang Y; Bie L; Fu X; Zhang N
    J Cardiothorac Surg; 2020 Apr; 15(1):69. PubMed ID: 32326944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward improving prognosis prediction in patients undergoing small lung adenocarcinoma resection: Radiological and pathological assessment of diversity and intratumor heterogeneity.
    Koezuka S; Mikami T; Tochigi N; Sano A; Azuma Y; Makino T; Otsuka H; Matsumoto K; Shiraga N; Iyoda A
    Lung Cancer; 2019 Sep; 135():40-46. PubMed ID: 31447001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
    Zhang C; He Z; Cheng J; Cao J; Hu J
    Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non-Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes.
    Li M; Wang J; Bao X; Wang F; Zhou F; Song N; Wan Z; Li W; Zhang L
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431283. PubMed ID: 38809121
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term results after surgical treatment of the dominant lung adenocarcinoma associated with ground-glass opacities.
    Bongiolatti S; Corzani R; Borgianni S; Meniconi F; Cipollini F; Gonfiotti A; Viggiano D; Paladini P; Voltolini L
    J Thorac Dis; 2018 Aug; 10(8):4838-4848. PubMed ID: 30233857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive adenocarcinoma manifesting as pure ground glass nodule with different size: radiological characteristics differ while prognosis remains the same.
    Wang Z; Zhu W; Lu Z; Li W; Shi J
    Transl Cancer Res; 2021 Jun; 10(6):2755-2766. PubMed ID: 35116586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma.
    Shang J; Jiang H; Zhao Y; Lai J; Shi L; Yang J; Chen H; Zheng Y
    EBioMedicine; 2023 Aug; 94():104728. PubMed ID: 37506543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characteristics of lung adenocarcinoma with ground-glass opacity component.
    Zhu W; Bai N; Cao J; Yang F; Chen D
    J Thorac Dis; 2023 Nov; 15(11):6106-6114. PubMed ID: 38090297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical outcomes of one-stage resection for synchronous multiple primary lung adenocarcinomas with no less than three lesions.
    Qu R; Tu D; Ping W; Cai Y; Zhang N; Fu X
    J Cardiothorac Surg; 2021 Sep; 16(1):265. PubMed ID: 34544453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Prognostic Factors of Ground Glass Opacity and Pure-Solid Lesion in Pathological Stage I Invasive Lung Adenocarcinoma.
    Zhai WY; Wong WS; Duan FF; Liang DC; Gong L; Dai SQ; Wang JY
    World J Oncol; 2022 Oct; 13(5):259-271. PubMed ID: 36406190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.